Susan B. Barrett

Bayview Avenue
Clayton, VIC 3168, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Crowder-directed interactions and conformational dynamics in multistimuli-responsive intrinsically disordered protein.

Crowder-directed interactions and conformational dynamics in multistimuli-responsive intrinsically disordered protein.

Journal: Science advances

Published: December 21, 2022

Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.

Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.

Journal: Antiviral research

Published: April 15, 2019

Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro- N-acetylneuraminic Acid Derivatives.

Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro- N-acetylneuraminic Acid Derivatives.

Journal: Journal of medicinal chemistry

Published: February 06, 2018

Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.

Identification of Indonesian clade 2.1 highly pathogenic influenza A(H5N1) viruses with N294S and S246N neuraminidase substitutions which further reduce oseltamivir susceptibility.

Journal: Antiviral research

Published: December 18, 2017

Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid Detection of Influenza Virus Infection.

Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid Detection of Influenza Virus Infection.

Journal: Journal of clinical microbiology

Published: July 26, 2016

Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).

Catalytic mechanism and novel receptor binding sites of human parainfluenza virus type 3 hemagglutinin-neuraminidase (hPIV3 HN).

Journal: Antiviral research

Published: July 20, 2015

Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation.

Neuraminidase mutations conferring resistance to laninamivir lead to faster drug binding and dissociation.

Journal: Antiviral research

Published: September 12, 2014

Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removal.

Solid phase assay for comparing reactivation rates of neuraminidases of influenza wild type and resistant mutants after inhibitor removal.

Journal: Antiviral research

Published: February 05, 2014

Feeling that life is not worth living (death thoughts) among middle-aged, Australian women providing unpaid care.

Feeling that life is not worth living (death thoughts) among middle-aged, Australian women providing unpaid care.

Journal: Maturitas

Published: January 13, 2014

Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase.

Journal: The Journal of antimicrobial chemotherapy

Published: June 14, 2013

I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses.

I222 Neuraminidase mutations further reduce oseltamivir susceptibility of Indonesian Clade 2.1 highly pathogenic Avian Influenza A(H5N1) viruses.

Journal: PloS one

Published: January 13, 2013

In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.

In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.

Journal: The Journal of antimicrobial chemotherapy

Published: May 08, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026